HEADER TRANSFERASE 19-MAR-09 2WD1 TITLE HUMAN C-MET KINASE IN COMPLEX WITH AZAINDOLE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEPATOCYTE GROWTH FACTOR RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN, RESIDUES 1055-1346; COMPND 5 SYNONYM: SCATTER FACTOR RECEPTOR, HGF/SF RECEPTOR, MET PROTO-ONCOGENE COMPND 6 TYROSINE KINASE, C-MET; COMPND 7 EC: 2.7.10.1; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS KEYWDS HUMAN KINASE, C-MET, AZAINDOLE, INHIBITOR, TRANSFERASE, KINASE, KEYWDS 2 NUCLEOTIDE-BINDING, ATP-BINDING, TYROSINE-PROTEIN KINASE EXPDTA X-RAY DIFFRACTION AUTHOR J.PORTER,S.LUMB,R.J.FRANKLIN,J.M.GASCON-SIMORTE,M.CALMIANO,K.LE AUTHOR 2 RICHE,B.LALLEMAND,J.KEYAERTS,H.EDWARDS,A.MALONEY,J.DELGADO,L.KING, AUTHOR 3 A.FOLEY,F.LECOMTE,J.REUBERSON,C.MEIER,M.BATCHELOR REVDAT 4 08-MAY-24 2WD1 1 REMARK REVDAT 3 25-AUG-09 2WD1 1 JRNL REMARK REVDAT 2 12-MAY-09 2WD1 1 JRNL REVDAT 1 28-APR-09 2WD1 0 JRNL AUTH J.PORTER,S.LUMB,R.J.FRANKLIN,J.M.GASCON-SIMORTE,M.CALMIANO, JRNL AUTH 2 K.L.RICHE,B.LALLEMAND,J.KEYAERTS,H.EDWARDS,A.MALONEY, JRNL AUTH 3 J.DELGADO,L.KING,A.FOLEY,F.LECOMTE,J.REUBERSON,C.MEIER, JRNL AUTH 4 M.BATCHELOR JRNL TITL DISCOVERY OF 4-AZAINDOLES AS NOVEL INHIBITORS OF C- MET JRNL TITL 2 KINASE. JRNL REF BIOORG.MED.CHEM.LETT. V. 19 2780 2009 JRNL REFN ISSN 0960-894X JRNL PMID 19369077 JRNL DOI 10.1016/J.BMCL.2009.03.110 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0005 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 42.37 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 17224 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.212 REMARK 3 R VALUE (WORKING SET) : 0.210 REMARK 3 FREE R VALUE : 0.265 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.300 REMARK 3 FREE R VALUE TEST SET COUNT : 774 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.05 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1243 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 BIN R VALUE (WORKING SET) : 0.2710 REMARK 3 BIN FREE R VALUE SET COUNT : 55 REMARK 3 BIN FREE R VALUE : 0.3450 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2303 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 36 REMARK 3 SOLVENT ATOMS : 71 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 20.44 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.241 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.202 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.167 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 6.152 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.922 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.881 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2408 ; 0.009 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 2195 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3270 ; 1.148 ; 1.976 REMARK 3 BOND ANGLES OTHERS (DEGREES): 5098 ; 0.779 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 295 ; 5.925 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 98 ;30.675 ;23.163 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 405 ;14.111 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 13 ;15.695 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 360 ; 0.069 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2659 ; 0.003 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 498 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 490 ; 0.197 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 2163 ; 0.179 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1193 ; 0.177 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 1247 ; 0.083 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 93 ; 0.167 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 18 ; 0.157 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 91 ; 0.220 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 8 ; 0.129 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1902 ; 2.399 ; 2.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 596 ; 0.540 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2382 ; 2.897 ; 3.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1116 ; 4.079 ; 4.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 888 ; 5.064 ; 6.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 2WD1 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 19-MAR-09. REMARK 100 THE DEPOSITION ID IS D_1290039115. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-FEB-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 18000 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 42.370 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 200 DATA REDUNDANCY : 4.000 REMARK 200 R MERGE (I) : 0.13000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 12.4300 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.10 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.4 REMARK 200 DATA REDUNDANCY IN SHELL : 4.00 REMARK 200 R MERGE FOR SHELL (I) : 0.49000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 4.220 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CCP4 REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 39.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.98 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 21.15600 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 1149 REMARK 465 GLU A 1150 REMARK 465 GLY A 1151 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 LYS A 1104 CE NZ REMARK 480 GLU A 1127 CD OE1 OE2 REMARK 480 SER A 1152 OG REMARK 480 LYS A 1240 CB CG CD CE NZ REMARK 480 GLN A 1258 CD OE1 NE2 REMARK 480 THR A 1289 CB OG1 CG2 REMARK 480 LYS A 1323 CD CE NZ REMARK 480 GLU A 1325 CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A1067 -55.90 -24.27 REMARK 500 ASN A1100 -58.45 -21.84 REMARK 500 SER A1135 104.06 -167.18 REMARK 500 ARG A1203 -7.55 71.70 REMARK 500 ASP A1204 43.43 -149.14 REMARK 500 THR A1241 -18.00 -143.52 REMARK 500 REMARK 500 REMARK: NULL REMARK 700 REMARK 700 SHEET REMARK 700 THE SHEET STRUCTURE OF THIS MOLECULE IS BIFURCATED. IN REMARK 700 ORDER TO REPRESENT THIS FEATURE IN THE SHEET RECORDS BELOW, REMARK 700 TWO SHEETS ARE DEFINED. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZZY A 2347 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GBL A 2348 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GBL A 2349 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1R1W RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THEHEPATOCYTE REMARK 900 GROWTH FACTOR RECEPTOR C-MET REMARK 900 RELATED ID: 1UX3 RELATED DB: PDB REMARK 900 3D STRUCTURE PREDICTION OF AMINO ACIDS 25 TO 656 OF HUMAN REMARK 900 HEPATOCYTE GROWTH FACTOR/ SCATTER FACTOR (MET) RECEPTOR REMARK 900 RELATED ID: 1FYR RELATED DB: PDB REMARK 900 DIMER FORMATION THROUGH DOMAIN SWAPPING IN THE CRYSTALSTRUCTURE OF REMARK 900 THE GRB2-SH2 AC- PYVNV COMPLEX REMARK 900 RELATED ID: 1SHY RELATED DB: PDB REMARK 900 THE CRYSTAL STRUCTURE OF HGF BETA-CHAIN IN COMPLEX WITH THESEMA REMARK 900 DOMAIN OF THE MET RECEPTOR. REMARK 900 RELATED ID: 2UZX RELATED DB: PDB REMARK 900 STRUCTURE OF THE HUMAN RECEPTOR TYROSINE KINASE MET IN COMPLEX WITH REMARK 900 THE LISTERIA MONOCYTOGENES INVASION PROTEIN INLB: CRYSTAL FORM I REMARK 900 RELATED ID: 2CEW RELATED DB: PDB REMARK 900 3D STRUCTURE PREDICTION OF THE IG2-IG4 DOMAINS OF THE ECTODOMAIN REMARK 900 REGION OF THE HUMAN HEPATOCYTE GROWTH FACTOR-SCATTER FACTOR REMARK 900 RECEPTOR, MET REMARK 900 RELATED ID: 2UZY RELATED DB: PDB REMARK 900 STRUCTURE OF THE HUMAN RECEPTOR TYROSINE KINASE MET IN COMPLEX WITH REMARK 900 THE LISTERIA MONOCYTOGENES INVASION PROTEIN INLB: LOW RESOLUTION, REMARK 900 CRYSTAL FORM II REMARK 900 RELATED ID: 2G15 RELATED DB: PDB REMARK 900 STRUCTURAL CHARACTERIZATION OF AUTOINHIBITED C- MET KINASE REMARK 900 RELATED ID: 1SSL RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF THE PSI DOMAIN FROM THE MET RECEPTOR REMARK 900 RELATED ID: 1R0P RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THEHEPATOCYTE REMARK 900 GROWTH FACTOR RECEPTOR C-MET IN COMPLEX WITHTHE MICROBIAL ALKALOID REMARK 900 K-252A REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE CONFLICT DESCRIBED IN THE SEQADV RECORDS BELOW IS REMARK 999 ANNOTATED IN THE UNIPROT DATABASE AND HAS BEEN DESCRIBED REMARK 999 IN PUBMED ID: 12853948 AND 3325883. DBREF 2WD1 A 1055 1346 UNP P08581 MET_HUMAN 1055 1346 SEQADV 2WD1 LEU A 1272 UNP P08581 VAL 1272 SEE REMARK 999 SEQRES 1 A 292 LEU SER ALA LEU ASN PRO GLU LEU VAL GLN ALA VAL GLN SEQRES 2 A 292 HIS VAL VAL ILE GLY PRO SER SER LEU ILE VAL HIS PHE SEQRES 3 A 292 ASN GLU VAL ILE GLY ARG GLY HIS PHE GLY CYS VAL TYR SEQRES 4 A 292 HIS GLY THR LEU LEU ASP ASN ASP GLY LYS LYS ILE HIS SEQRES 5 A 292 CYS ALA VAL LYS SER LEU ASN ARG ILE THR ASP ILE GLY SEQRES 6 A 292 GLU VAL SER GLN PHE LEU THR GLU GLY ILE ILE MET LYS SEQRES 7 A 292 ASP PHE SER HIS PRO ASN VAL LEU SER LEU LEU GLY ILE SEQRES 8 A 292 CYS LEU ARG SER GLU GLY SER PRO LEU VAL VAL LEU PRO SEQRES 9 A 292 TYR MET LYS HIS GLY ASP LEU ARG ASN PHE ILE ARG ASN SEQRES 10 A 292 GLU THR HIS ASN PRO THR VAL LYS ASP LEU ILE GLY PHE SEQRES 11 A 292 GLY LEU GLN VAL ALA LYS GLY MET LYS TYR LEU ALA SER SEQRES 12 A 292 LYS LYS PHE VAL HIS ARG ASP LEU ALA ALA ARG ASN CYS SEQRES 13 A 292 MET LEU ASP GLU LYS PHE THR VAL LYS VAL ALA ASP PHE SEQRES 14 A 292 GLY LEU ALA ARG ASP MET TYR ASP LYS GLU TYR TYR SER SEQRES 15 A 292 VAL HIS ASN LYS THR GLY ALA LYS LEU PRO VAL LYS TRP SEQRES 16 A 292 MET ALA LEU GLU SER LEU GLN THR GLN LYS PHE THR THR SEQRES 17 A 292 LYS SER ASP VAL TRP SER PHE GLY VAL LEU LEU TRP GLU SEQRES 18 A 292 LEU MET THR ARG GLY ALA PRO PRO TYR PRO ASP VAL ASN SEQRES 19 A 292 THR PHE ASP ILE THR VAL TYR LEU LEU GLN GLY ARG ARG SEQRES 20 A 292 LEU LEU GLN PRO GLU TYR CYS PRO ASP PRO LEU TYR GLU SEQRES 21 A 292 VAL MET LEU LYS CYS TRP HIS PRO LYS ALA GLU MET ARG SEQRES 22 A 292 PRO SER PHE SER GLU LEU VAL SER ARG ILE SER ALA ILE SEQRES 23 A 292 PHE SER THR PHE ILE GLY HET ZZY A2347 24 HET GBL A2348 6 HET GBL A2349 6 HETNAM ZZY 1-[(2-NITROPHENYL)SULFONYL]-1H-PYRROLO[3,2-B]PYRIDINE- HETNAM 2 ZZY 6-CARBOXAMIDE HETNAM GBL GAMMA-BUTYROLACTONE HETSYN GBL DIHYDROFURAN-2(3H)-ONE FORMUL 2 ZZY C14 H10 N4 O5 S FORMUL 3 GBL 2(C4 H6 O2) FORMUL 5 HOH *71(H2 O) HELIX 1 1 ASN A 1059 GLN A 1067 1 9 HELIX 2 2 GLY A 1072 SER A 1074 5 3 HELIX 3 3 ASP A 1117 PHE A 1134 1 18 HELIX 4 4 ASP A 1164 ASN A 1171 1 8 HELIX 5 5 THR A 1177 LYS A 1198 1 22 HELIX 6 6 ALA A 1206 ARG A 1208 5 3 HELIX 7 7 PHE A 1223 ARG A 1227 5 5 HELIX 8 8 ASP A 1231 TYR A 1235 5 5 HELIX 9 9 PRO A 1246 MET A 1250 5 5 HELIX 10 10 ALA A 1251 GLN A 1258 1 8 HELIX 11 11 THR A 1261 THR A 1278 1 18 HELIX 12 12 ASN A 1288 PHE A 1290 5 3 HELIX 13 13 ASP A 1291 GLN A 1298 1 8 HELIX 14 14 PRO A 1309 TRP A 1320 1 12 HELIX 15 15 LYS A 1323 ARG A 1327 5 5 HELIX 16 16 SER A 1329 THR A 1343 1 15 SHEET 1 AA 3 LEU A1076 VAL A1078 0 SHEET 2 AA 3 GLY A1090 LEU A1098 -1 O THR A1096 N ILE A1077 SHEET 3 AA 3 GLY A1085 ARG A1086 -1 O GLY A1085 N VAL A1092 SHEET 1 AB 5 LEU A1076 VAL A1078 0 SHEET 2 AB 5 GLY A1090 LEU A1098 -1 O THR A1096 N ILE A1077 SHEET 3 AB 5 LYS A1104 LEU A1112 -1 O ILE A1105 N LEU A1097 SHEET 4 AB 5 LEU A1154 PRO A1158 -1 O VAL A1155 N LYS A1110 SHEET 5 AB 5 GLY A1144 CYS A1146 -1 O GLY A1144 N VAL A1156 SHEET 1 AC 2 CYS A1210 LEU A1212 0 SHEET 2 AC 2 VAL A1218 VAL A1220 -1 O LYS A1219 N MET A1211 SHEET 1 AD 2 SER A1236 VAL A1237 0 SHEET 2 AD 2 LYS A1244 LEU A1245 -1 O LEU A1245 N SER A1236 SITE 1 AC1 14 ILE A1084 VAL A1092 ALA A1108 LEU A1140 SITE 2 AC1 14 LEU A1157 PRO A1158 TYR A1159 MET A1160 SITE 3 AC1 14 ARG A1208 MET A1211 ALA A1221 ASP A1222 SITE 4 AC1 14 ALA A1226 TYR A1230 SITE 1 AC2 6 MET A1131 LEU A1140 LEU A1157 PHE A1223 SITE 2 AC2 6 LEU A1225 ALA A1226 SITE 1 AC3 7 PHE A1089 ASP A1204 ARG A1227 ASP A1228 SITE 2 AC3 7 MET A1229 TYR A1235 LYS A1244 CRYST1 37.411 42.312 84.826 90.00 93.01 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.026730 0.000000 0.001406 0.00000 SCALE2 0.000000 0.023634 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011805 0.00000